Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 10:51 AM ET

Date/Time Source News Release
06/04/2025 07:00 AM EDT GlobeNewswire Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
05/19/2025 07:00 AM EDT GlobeNewswire Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
05/17/2025 07:15 AM EDT GlobeNewswire Fractyl Health Unveils New Rejuva® Smart GLP-1(TM) Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
05/13/2025 04:05 PM EDT GlobeNewswire Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
05/06/2025 07:00 AM EDT GlobeNewswire Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
04/28/2025 04:30 PM EDT GlobeNewswire Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
04/01/2025 07:00 AM EDT GlobeNewswire Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
03/03/2025 04:05 PM EST GlobeNewswire Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
02/24/2025 07:00 AM EST GlobeNewswire Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
01/31/2025 08:01 AM EST GlobeNewswire Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025
Page
  • 1
  • 2

Additional News

As of June 10, 2025 • 10:51 AM ET

Date/Time Source News Release
06/09/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Biotech Longevity Hopes and Weight Loss Funding Drive Market Action
05/14/2025 12:45 AM EDT SeekingAlpha Orchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism
05/13/2025 08:43 PM EDT SeekingAlpha Fractyl signals accelerated enrollment for REMAIN-1 study while advancing Rejuva clinical milestones
05/13/2025 08:43 PM EDT SeekingAlpha Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript
05/13/2025 04:26 PM EDT SeekingAlpha Fractyl Health reports Q1 results
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Fractyl Health, Inc.
05/12/2025 06:48 PM EDT KlickAnalytics GUTS - Historical Price Movements Surrounding Earnings
05/12/2025 06:43 PM EDT KlickAnalytics GUTS - Historical Earnings Price Analysis
03/03/2025 08:01 PM EST SeekingAlpha Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.